对多发性肌痛风湿和巨细胞动脉炎的2/3期试验的审查
Pratheeshaa Nageswaran1, Saad Ahmed2, Hasan Tahir1,3
1Department of Rheumatology, Royal Free London NHS Trust, London, UK.
Expert opinion on emerging drugs
|January 5, 2024
概括
巨细胞动脉炎 (GCA) 和多肌痛性类风湿 (PMR) 是老年人的炎症状况. 本综述探讨了当前和新兴的治疗方法,强调了GCA和PMR的未满足需求和新的治疗目标.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 巨细胞动脉炎 (GCA) 和多肌痛性类风湿 (PMR) 是影响老年人的炎症性类风湿性疾病.
- 这两种情况都有重叠的特征和宪法症状.
- GCA涉及中大动脉炎症,而PMR则表现为肌肉硬.
研究的目的:
- 审查GCA和PMR的既定和即将到来的治疗方法.
- 确定新的和有前途的治疗策略.
- 评估当前的治疗环境和正在进行的临床试验.
主要方法:
- 关于GCA和PMR治疗的现有文献的全面审查.
- 分析已完成和即将进行的临床试验.
- 评估新的治疗作用机制.
主要成果:
- 葡萄糖皮质体 (GC) 对于初始管理至关重要,但由于毒性问题,需要使用GC节约剂.
- 目前,GCA和PMR的治疗选择有限,有显著的未满足需求.
- 新兴疗法针对的是CD4 T细胞协同刺激,IL-17,IL-12/23,GM-CSF,IL-1β,TNF-α和JAK抑制等途径.
结论:
- 对于GCA和PMR来说,急需改进和多样化治疗选择.
- 新的治疗目标和作用机制显示了未来GCA和PMR管理的前景.
- 进一步的研究和临床试验对于解决这些条件下未满足的需求至关重要.
相关概念视频
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Phase II Reactions: Glucuronidation
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...


